Biota Holdings Limited - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Biota Holdings Limited. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Biota Holdings Limited. The Group's principal activity is discovering and developing antiviral drugs. The Group's operation focuses on the development of Zanamivir, neuraminidase inhibitor for the treatment and prevention of influenza. Its research outcomes have included nucleoside analogues designed to treat hepatitis C virus (HCV) infections, licensed to Boehringer Ingelheim, and a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease. It operates in Australia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report